Pediatrics (all articles)
Prevalence and trend of smokeless tobacco use among adolescents aged 12–16 years in 138 countries/territories.
29 Nov, 2022 | 13:47h | UTC
WHO recommendations for care of the preterm or low-birth-weight infant.
27 Nov, 2022 | 22:31h | UTCWHO recommendations for care of the preterm or low-birth-weight infant – World Health Organization
News Release: Launch of the WHO recommendations for care of the preterm or low birth weight infant – World Health Organization
Commentary on Twitter (thread – click for more)
? Ahead of #WorldPrematurityDay (17 Nov.), WHO published new guidelines to improve survival and health outcomes for babies born early (before 37 weeks of pregnancy) or small (under 2.5kg at birth) https://t.co/Jl0dg5TMAs pic.twitter.com/ZBn35RwE9G
— World Health Organization (WHO) (@WHO) November 15, 2022
RCT | One-session treatment compared with multisession CBT in children aged 7-16 years with specific phobias.
27 Nov, 2022 | 22:07h | UTC
Commentary on Twitter
One-session treatment and cognitive–behavioural therapy worked just as well as multisession cognitive–behavioural therapy for treating phobias in children and young people. It's also highly likely to be cost-saving.
Read the full report: https://t.co/i7M58yGfLv pic.twitter.com/ZEGgG4yh26
— NIHR Evidence (@NIHRevidence) November 25, 2022
Retrospective Cohort Study | Comparative analysis of all-terrain vehicles, motorcycle and automobile-related trauma in a rural community.
25 Nov, 2022 | 12:27h | UTCCommentaries:
Children very vulnerable to severe injury from quad bike use – BMJ Open
More Male, Pediatric Patients Suffer ATV-Related Injury – HealthDay
Related: AAP Recommendations | Prevention of pediatric all-terrain vehicles related deaths and injuries.
Commentary on Twitter
Children are very vulnerable to severe injury from the use of quad bikes, also known as ATVs, finds new research published in the open access journal @BMJ_Open. https://t.co/kjFKRiVgbZ#ATVs #quadbikes pic.twitter.com/njEFhEKgYZ
— BMJ (@bmj_company) October 28, 2022
WHO updates recommendations to guide family planning decisions.
24 Nov, 2022 | 13:38h | UTCNews Release: WHO updates recommendations to guide family planning decisions – World Health Organization
Family planning: A global handbook for providers – World Health Organization (PDF)
Commentary on Twitter (thread – click for more)
?WHO releases important updates to its Family Planning Handbook ?
⏭providing health workers and policymakers with the most updated information on contraceptive options.
Know more:?https://t.co/UhC1BFca2r pic.twitter.com/LQEtm3wmbZ
— World Health Organization (WHO) (@WHO) November 15, 2022
M-A | Prevalence and global estimates of unsafe listening practices in adolescents and young adults.
24 Nov, 2022 | 13:18h | UTCNews Release: 1 billion + young people potentially at risk of hearing loss from loud music – BMJ Newsroom
Commentary from the author on Twitter (with video summary).
Why risk your hearing when its possible to ‘hear for life’?
Listen with care! @WHO study shows that 1 billion young people risk hearing loss from loud music. https://t.co/ziDn5OOoJn
protect your ears by following simple tips for #safelistening @MikkelsenBente_ pic.twitter.com/jvMVGXDpPi— Shelly Chadha (@ShellyChadha1) November 22, 2022
RCT | Discontinuation vs. continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis.
23 Nov, 2022 | 13:36h | UTC
Commentary on Twitter
NEW Article—Discontinuing daily hypertonic saline or dornase alfa in #CFTR modulator-treated individuals with #cysticfibrosis: the SIMPLIFY study
From Nicole Mayer-Hamblett & colleagues https://t.co/LwVctcOlTq#NACFC2022 @CF_Foundation pic.twitter.com/OnDe8rUoPx
— The Lancet Respiratory Medicine (@LancetRespirMed) November 4, 2022
RCT | Leniolisib for Activated phosphoinositide 3-kinase delta syndrome.
22 Nov, 2022 | 13:12h | UTC
Post-trial follow-up | A brief intervention to prevent alcohol use can have sustained effects among high-risk adolescents.
22 Nov, 2022 | 13:08h | UTC
Commentary on Twitter
RCT: Personality-targeted school-based prevention program “Preventure” can effectively reduce alcohol-related harms up to 7 years later, showing the meaningful & sustained benefits of school-based prevention programs. @theMatilda_USyd https://t.co/HuoZZluc6I #OAResearch
— JAMA Network Open (@JAMANetworkOpen) November 17, 2022
Cohort Study | Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children.
21 Nov, 2022 | 14:33h | UTCAssociation of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in Children – JAMA Internal Medicine (link to abstract – $ for full-text)
Commentaries:
Antidepressants in Pregnancy Do Not Affect Child Neurodevelopment – HealthDay
Commentary on Twitter
https://twitter.com/JAMAInternalMed/status/1593046260440776704
Crossover RCT | Spectacle lenses with highly aspherical lenslets for slowing myopia.
17 Nov, 2022 | 12:16h | UTCRelated:
M-A | A short course of antibiotics is noninferior to long-course therapy in children with nonsevere pneumonia.
16 Nov, 2022 | 13:43h | UTCShort-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis – JAMA Pediatrics (free for a limited period)
Commentary: Review: Shorter antibiotic course sufficient for kids with pneumonia – CIDRAP
Related:
ACP Guidance: Appropriate Use of Short-Course Antibiotics in Common Infections
RCT: 7 days of antibiotic therapy as good as 14 days for afebrile men with urinary tract infection.
Meta-Analysis: Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia
SR | Masks vs. prongs as interfaces for nasal continuous positive airway pressure in preterm infants.
16 Nov, 2022 | 13:31h | UTC
Editorial | The urgent need to recognize and properly address prenatal-onset group B Streptococcus disease.
10 Nov, 2022 | 13:59h | UTC
Case-control study | Risk variants in the exomes of children with critical illness.
10 Nov, 2022 | 13:52h | UTCRisk Variants in the Exomes of Children With Critical Illness – JAMA Network Open
Guideline | Intravenous maintenance fluid therapy in acute and critically ill children.
9 Nov, 2022 | 12:32h | UTC
Commentary on Twitter
The @ESPNIC_Society guidelines for IV maintenance fluid therapy in acute & critically ill children, SR/MA:
➡️indications for use
?isotonic fluids
?balanced solutions
?composition: Ca, Mg, K, glucose, micronutrients
?optimal amount#PedsICU #FOAMcc
?️https://t.co/ZZwHX1IaUh pic.twitter.com/KGr4e2dFg4— Intensive Care Medicine (@yourICM) October 26, 2022
AHA Scientific Statement | Arrhythmias in repaired Tetralogy of Fallot.
9 Nov, 2022 | 12:33h | UTCSummary: Arrhythmias in Repaired Tetralogy of Fallot – American Heart Association
Top Things to Know: Arrhythmias in Repaired Tetralogy of Fallot – American Heart Association
Commentary: Challenges in Managing Arrhythmias in Adult Tetralogy of Fallot – American Heart Association
RCT | In infants undergoing heart surgery, prophylactic methylprednisolone did not significantly improve outcomes.
9 Nov, 2022 | 12:31h | UTCMethylprednisolone for Heart Surgery in Infants — A Randomized, Controlled Trial – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Steroids during surgery may not be helpful for infants having heart bypass – American Heart Association
Commentary on Twitter
In this randomized, controlled trial involving infants undergoing surgery with cardiopulmonary bypass, prophylactic use of methylprednisolone did not significantly reduce the likelihood of a worse outcome. #AHA22 https://t.co/jaza6JCAuk pic.twitter.com/lLrxci7SaE
— NEJM (@NEJM) November 6, 2022
RCT | Effect of text messaging parents of school-aged children on outdoor time to control myopia.
9 Nov, 2022 | 12:26h | UTC
Commentary on Twitter
Using text message reminders to parents offer improved control of #myopia in schoolchildren and should be considered for use with large populations and over large geographic areas. https://t.co/6Dpue8j3Om #Research pic.twitter.com/IMpyGZUQyV
— JAMA Pediatrics (@JAMAPediatrics) September 26, 2022
Defining the optimum strategy for identifying adults and children with celiac disease: systematic review and economic modeling.
9 Nov, 2022 | 12:16h | UTC
Cohort Study | Associations between childhood trauma and childhood psychiatric disorders in Brazil.
9 Nov, 2022 | 12:15h | UTCCommentary: Birth cohort study reveals the mental health burden of trauma in childhood – University of Bath
RCT | Efficacy and safety of methylphenidate and behavioral parent training for children aged 3–5 years with ADHD.
9 Nov, 2022 | 12:09h | UTCEfficacy and safety of methylphenidate and behavioural parent training for children aged 3–5 years with attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled, and sham behavioural parent training-controlled trial – The Lancet Child & Adolescent Health (link to abstract – $ for full-text)
Commentary on Twitter (thread – click for more)
Methylphenidate was effective in reducing #ADHD symptoms and improving functionality, and behavioural parent training was effective in improving functionality for preschool children with ADHD after 8 weeks of treatment.
New RCT by @gvpolanczyk & team: https://t.co/iDUhRMTno4
— The Lancet Child & Adolescent Health (@LancetChildAdol) October 26, 2022
Guideline | Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients.
8 Nov, 2022 | 12:21h | UTC
RCT | Early amino acids in extremely preterm infants did improve neurodisability at 2 Years.
7 Nov, 2022 | 12:52h | UTCEarly Amino Acids in Extremely Preterm Infants and Neurodisability at 2 Years – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Extra Parenteral Amino Acids No Benefit for Extremely Preterm Infants – HealthDay
Commentary on Twitter
ProVIDE trial @NEJM: In ELBW infants, extra parenteral amino acids at a dose of 1 g/day for 5 days after birth did not improve survival free from neurodisability at 2 yrs.
Higher rates of mod-sev disability noted in intervention group.https://t.co/8hT3Ol3qOi#EBNEOalerts #neoEBM pic.twitter.com/2Z9qgkQF54— Evidence-Based Neo (@EBNEO) November 5, 2022
RCT | Once-weekly Semaglutide effective for weight loss in adolescents with obesity.
4 Nov, 2022 | 13:59h | UTCOnce-Weekly Semaglutide in Adolescents with Obesity – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
STEP TEENS: High-dose semaglutide weight loss benefits shown in adolescents – medwire News
Trial Shows Weight-Loss Drug Works in Teens – HealthDay
Commentary on Twitter
In this trial, adolescents with obesity assigned to weekly subcutaneous semaglutide plus lifestyle intervention had a greater reduction in BMI than those who received lifestyle intervention alone. https://t.co/yiFseP38xa pic.twitter.com/uRqkFfon1s
— NEJM (@NEJM) November 2, 2022